Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
C. Korin Bullen, Gregory M. Laird, Christine M. Durand, et al.
Nature Medicine (2014) Vol. 20, Iss. 4, pp. 425-429
Open Access | Times Cited: 479

Showing 1-25 of 479 citing articles:

Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Katrina J. Falkenberg, Ricky W. Johnstone
Nature Reviews Drug Discovery (2014) Vol. 13, Iss. 9, pp. 673-691
Closed Access | Times Cited: 1371
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
Thomas A. Rasmussen, Martin Tolstrup, Christel R. Brinkmann, et al.
The Lancet HIV (2014) Vol. 1, Iss. 1, pp. e13-e21
Closed Access | Times Cited: 584
Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
Julian H Elliott, Fiona Wightman, Ajantha Solomon, et al.
PLoS Pathogens (2014) Vol. 10, Iss. 11, pp. e1004473-e1004473
Open Access | Times Cited: 483
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
Ole S. Søgaard, Mette E Graversen, Steffen Leth, et al.
PLoS Pathogens (2015) Vol. 11, Iss. 9, pp. e1005142-e1005142
Open Access | Times Cited: 478
PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals
Riddhima Banga, Francesco A. Procopio, Alessandra Noto, et al.
Nature Medicine (2016) Vol. 22, Iss. 7, pp. 754-761
Closed Access | Times Cited: 423
Ex vivo analysis identifies effective HIV-1 latency–reversing drug combinations
Gregory M. Laird, C. Korin Bullen, Daniel I. S. Rosenbloom, et al.
Journal of Clinical Investigation (2015) Vol. 125, Iss. 5, pp. 1901-1912
Open Access | Times Cited: 375
Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice
Ariel Halper-Stromberg, Ching-Lan Lu, Florian Klein, et al.
Cell (2014) Vol. 158, Iss. 5, pp. 989-999
Open Access | Times Cited: 356
Targeting the Latent Reservoir for HIV-1
Srona Sengupta, Robert F. Siliciano
Immunity (2018) Vol. 48, Iss. 5, pp. 872-895
Open Access | Times Cited: 314
Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing
Rafal Kaminski, Yilan Chen, Tracy Fischer, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 300
HIV-1 DNA predicts disease progression and post-treatment virological control
James P. Williams, Jacob Hurst, Wolfgang Stöhr, et al.
eLife (2014) Vol. 3
Open Access | Times Cited: 290
The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption
Jonathan Z. Li, Behzad Etemad, Hayat Ahmed, et al.
AIDS (2015), pp. 1-1
Open Access | Times Cited: 282
HIV latency in isolated patient CD4 + T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing
Steven A. Yukl, Philipp Kaiser, Peggy Kim, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 430
Open Access | Times Cited: 278
Eradicating HIV-1 infection: seeking to clear a persistent pathogen
Nancie M. Archin, Julia Marsh Sung, Carolina Garrido, et al.
Nature Reviews Microbiology (2014) Vol. 12, Iss. 11, pp. 750-764
Open Access | Times Cited: 268
Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1
Alison L. Hill, Daniel I. S. Rosenbloom, Feng Fu, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 37, pp. 13475-13480
Open Access | Times Cited: 266
HIV
Jade Ghosn, Babafemi Taiwo, Soraya Seedat, et al.
The Lancet (2018) Vol. 392, Iss. 10148, pp. 685-697
Closed Access | Times Cited: 264
An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression
Gilles Darcis, Anna Kula, Sophie Bouchat, et al.
PLoS Pathogens (2015) Vol. 11, Iss. 7, pp. e1005063-e1005063
Open Access | Times Cited: 261
A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals
Francesco A. Procopio, Rémi Fromentin, Deanna A. Kulpa, et al.
EBioMedicine (2015) Vol. 2, Iss. 8, pp. 874-883
Open Access | Times Cited: 255
Latency reversal and viral clearance to cure HIV-1
David M. Margolis, J. Víctor García, Daria J. Hazuda, et al.
Science (2016) Vol. 353, Iss. 6297
Open Access | Times Cited: 221
HIV reservoirs as obstacles and opportunities for an HIV cure
Tae‐Wook Chun, Susan Moir, Anthony S. Fauci
Nature Immunology (2015) Vol. 16, Iss. 6, pp. 584-589
Open Access | Times Cited: 212
Understanding HIV Latency: The Road to an HIV Cure
Matthew S. Dahabieh, Emilie Battivelli, Eric Verdin
Annual Review of Medicine (2015) Vol. 66, Iss. 1, pp. 407-421
Open Access | Times Cited: 203
Immunologic strategies for HIV-1 remission and eradication
Dan H. Barouch, Steven G. Deeks
Science (2014) Vol. 345, Iss. 6193, pp. 169-174
Open Access | Times Cited: 200
Defective HIV-1 proviruses produce viral proteins
Hiromi Imamichi, Mindy Smith, Joseph W. Adelsberger, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 7, pp. 3704-3710
Open Access | Times Cited: 191
Long noncoding RNA NRON contributes to HIV-1 latency by specifically inducing tat protein degradation
Jun Li, Cancan Chen, Xiancai Ma, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 189
Towards an HIV-1 cure: measuring the latent reservoir
Katherine M. Bruner, Nina N. Hosmane, Robert F. Siliciano
Trends in Microbiology (2015) Vol. 23, Iss. 4, pp. 192-203
Open Access | Times Cited: 186
Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy
Carolina Gutiérrez, Sergio Serrano‐Villar, Nadia Madrid-Elena, et al.
AIDS (2016) Vol. 30, Iss. 9, pp. 1385-1392
Closed Access | Times Cited: 184
Page 1 - Next Page

Scroll to top